VolitionRX Ltd (VNRX): Next-Year EPS Estimate 40.49%
As of 2026-06-04, VolitionRX Ltd (VNRX) has a next-year EPS growth estimate of 40.49%. Featured in our EPS revision report on 2026-05-25.
On 2026-06-02, analyst consensus for VNRX's next-year EPS growth shifted from 37.45% to 40.49% — a positive change of 3.04 percentage points. The revised estimate has been sustained across 3 subsequent trading sessions. Current-year growth is projected at 47.05%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Medical Devices
- EPS growth next year
- 40.49%
- EPS growth this year
- 47.05%
- EPS next quarter (est)
- -$0.62
- Last price
- $2.08
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 40.49% | 47.05% | -$0.62 | $2.08 |
| 2026-06-03 | 40.49% | 47.05% | -$0.62 | $2.08 |
| 2026-06-02 | 40.49% | 47.05% | -$0.62 | $2.32 |
| 2026-06-01 | 37.45% | 45.32% | -$0.65 | $2.65 |
| 2026-05-31 | 37.45% | 45.32% | -$0.65 | $2.67 |
| 2026-05-28 | 37.45% | 45.32% | -$0.65 | $2.88 |
| 2026-05-27 | 37.45% | 45.32% | -$0.65 | $2.94 |
| 2026-05-26 | 37.45% | 45.32% | -$0.65 | $2.94 |
| 2026-05-25 | 37.45% | 45.32% | -$0.65 | $3.13 |
| 2026-05-24 | 37.45% | 45.32% | -$0.65 | $3.13 |
| 2026-05-21 | 241.25% | 58.22% | -$0.65 | $2.70 |
| 2026-05-20 | 241.25% | 58.22% | -$0.65 | $2.49 |
| 2026-05-19 | 226.94% | 56.97% | -$0.69 | $2.35 |
| 2026-05-18 | 219.45% | 55.61% | -$0.71 | $2.28 |
| 2026-05-17 | 219.45% | 55.61% | -$0.71 | $2.00 |
| 2026-05-14 | 219.45% | 55.61% | -$0.73 | $2.20 |
| 2026-05-13 | 219.45% | 55.61% | -$0.73 | $2.23 |
| 2026-05-12 | 219.45% | 55.61% | -$0.73 | $2.32 |
| 2026-05-11 | 219.45% | 55.61% | -$0.73 | $2.05 |
| 2026-05-10 | 219.45% | 55.61% | -$0.73 | $2.25 |
| 2026-05-07 | 219.45% | 55.61% | -$0.73 | $2.42 |
| 2026-05-06 | 219.45% | 55.61% | -$0.73 | $2.49 |
| 2026-05-05 | 219.45% | 55.61% | -$0.73 | $2.33 |
| 2026-05-04 | 219.45% | 55.61% | -$0.73 | $2.39 |
| 2026-05-03 | 219.45% | 55.61% | -$0.73 | $2.43 |
| 2026-04-30 | 219.45% | 55.61% | -$0.73 | $2.62 |
| 2026-04-29 | 218.64% | 55.30% | -$0.72 | $2.64 |
| 2026-04-28 | 218.64% | 55.30% | -$0.72 | $2.78 |
| 2026-04-27 | 218.64% | 55.30% | -$0.04 | $0.14 |
| 2026-04-26 | 226.81% | 58.18% | -$0.04 | $0.14 |
Reports Featuring VNRX
Recent News
- VolitionRX Ltd (VNRX) Q1 2026 Earnings Call Highlights: Revenue Surge and Strategic ...GuruFocus.com
- VolitionRX Ltd (VNRX) Q1 2026 Earnings Call Highlights: Revenue Surge and Strategic ...GuruFocus.com
- Volition Announces Breakthrough Finger-Prick Detection of Nucleosomes; Expanding Global Market Potential for Sepsis TestingPR Newswire
- VolitionRX: Q4 Earnings SnapshotAssociated Press
- VolitionRx Limited Announces Full Fiscal Year 2025 Financial Results and Business UpdatePR Newswire
- VolitionRx Limited Announces Full Fiscal Year 2025 Financial Results and Business UpdatePR Newswire
- VolitionRX Ltd (VNRX) Q4 2025: Everything You Need to Know Ahead of EarningsGuruFocus.com
- VolitionRX Ltd (VNRX) Q4 2025: Everything You Need to Know Ahead of EarningsGuruFocus.com
- VolitionRx Secures EUR 2.0 Million of Non-Dilutive Funding from Regional Government Agencies in BelgiumPR Newswire
- VolitionRx Secures EUR 2.0 Million of Non-Dilutive Funding from Regional Government Agencies in BelgiumPR Newswire
Screen Performance
Aggregate stats across all 1759 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +4.7%
- % of tickers in the green
- 61%
- Median return on winners
- +16.9%
- Large revisions captured
- 745
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is VolitionRX Ltd's next-year EPS growth estimate?▾
As of 2026-06-04, VolitionRX Ltd (VNRX) has a next-year EPS growth estimate of 40.49%, based on analyst consensus.
When was the latest EPS estimate revision for VNRX?▾
The most recent revision occurred on 2026-06-02, when analysts adjusted the next-year EPS growth estimate from 37.45% to 40.49%.
What sector and industry does VolitionRX Ltd belong to?▾
VolitionRX Ltd operates in the Healthcare sector, specifically the Medical Devices industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. VNRX appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. VolitionRX Ltd (VNRX) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports